Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System
Author(s): Vu Nicole T, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary
Issue: Nov/Dec 2008 - Arthritis and Immunological Diseases
View All Articles in Issue
Page(s): 558-564
Download in electronic PDF format for $75
Abstract: The objective of this study was to determine the stability of metronidazole benzoate suspension in SyrSpend SF One-Step Suspension System. The studied samples were packaged in 60-mL amber plastic prescription bottles, which were stored protected from light under controlled environmental conditions for a period of 360 days. Stability of metronidazole benzoate suspension in SyrSpend SF was assessed based on retention of initial color or appearance, pH of suspension, and recovery of metronidazole benzoate from the packaged product. Duplicate samples were evaluated at each predefined time interval. An assay method by high performance liquid chromatography was validated for its specificity and stability-indicating characteristics through a forced-degradation study, and was used in metronidazole benzoate assay. Metronidazole benzoate in SyrSpend SF retained its normal appearance of an opaque suspension, with acceptable pH values ranging from 4.43 to 4.53 (range 4.45 ± 0.5). Recovery of metronidazole benzoate at sub
Related Keywords:
Gary Schneider, RPh, FACA, stability, metronidazole, antibiotics, antimicrobial agents, commercial suspension system, storage
Related Categories:
EXCIPIENTS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, INFECTIOUS DISEASE
Printer-Friendly Version
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System
Vu Nicole T, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary
|
Nov/Dec 2008
Pg. 558-564
|
Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 320
|
Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets
Jarouche Marian, Ibrahim Martha, Pearson Jarryd, Low Mitchell, Rowe James
|
Jan/Feb 2020
Pg. 77-82
|
Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt
Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
|
Mar/Apr 2021
Pg. 169-175
|
Stability of Metronidazole Suspensions
Donnelly Ronald F, Ying James
|
May/Jun 2015
Pg. 248-251
|
Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 310-312
|
Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension
McElhiney Linda F
|
Jan/Feb 2021
Pg. 24-28
|
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 47
|
Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4
Espana B, Joseph-Tornabène F, Jaquet Cécile, Perrot S, Prouillac C
|
Jul/Aug 2020
Pg. 327-336
|
Stability of Ampicillin Sodium, Nafcillin Sodium, and Oxacillin Sodium in AutoDose Infusion System Bags
Zhang Yanping, Trissel Lawrence A
|
May/Jun 2002
Pg. 226-229
|
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
|
Mar/Apr 2008
Pg. 170-173
|
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers
Bhattacharya Sisir, Parekh Satish, Dedhiya Mahendra
|
Sep/Oct 2015
Pg. 432-436
|
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF
Geiger Christine M, Sorenson Bridget, Whaley Paul
|
Sep/Oct 2015
Pg. 420-427
|
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry
Geiger Christine M, Sorenson Bridget, Whaley Paul A
|
Jul/Aug 2013
Pg. 344-346
|
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Alexander Kenneth S, Thyangarajapuram N
|
Sep/Oct 2003
Pg. 389-393
|
Stability of Gentamicin Sulfate and Tobramycin Sulfate in AutoDose Infusion System Bags
Xu Quanyun A, Trissel Lawrence A, Saenz Christopher A, Ingram Delshalonda S
|
Mar/Apr 2002
Pg. 152-154
|
Stability of Allopurinol Suspension Compounded from Tablets
Alexander Kenneth S, Davar Nipun, Parker Gordon A
|
Mar/Apr 1997
Pg. 128-131
|
Benzoate or Not to Benzoate: Cats Are the Question, To
Davidson Gigi S
|
Mar/Apr 2001
Pg. 89-90
View Sample |
Stability and Dissolution of Lozenge and Emulsion Formulations of Metronidazole Benzoate
Fan Bin, Stewart James T, White Catherine A
|
Mar/Apr 2001
Pg. 153-156
|
Metronidazole Benzoate 400-mg/5-mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 46
|
| Return to Top |
